Inspire Medical Systems (INSP) reported $224.5 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 10.5%. EPS of $0.38 for the same period compares to $0.60 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $220.94 million, representing a surprise of +1.61%. The company delivered an EPS surprise of +353.33%, with the consensus EPS estimate being -$0.15.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Inspire performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Total U.S. sales territories: 336 compared to the 357 average estimate based on two analysts.
- Geographic Revenue- United States: $214.39 million compared to the $212.7 million average estimate based on six analysts. The reported number represents a change of +9.5% year over year.
- Geographic Revenue- All other countries: $10.11 million versus $9.01 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +37.3% change.
View all Key Company Metrics for Inspire here>>>
Shares of Inspire have returned -5.9% over the past month versus the Zacks S&P 500 composite's +2.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Inspire Medical Systems, Inc. (INSP): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
